or Try an Advanced Search...

    Technical Analysis for DNLI - Denali Therapeutics Inc.

    Grade Last Price % Change Price Change
    F 18.31 -1.93% -0.36
    DNLI closed down 1.93 percent on Friday, May 10, 2024, on 68 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. It ran into resistance at its 50 day moving average.
    Earnings due: May 31
    *** please verify all earnings dates ***
    3 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Down Down Up
    Historical DNLI trend table...
    Date Alert Name Type % Chg
    50 DMA Resistance Bearish 0.00%
    Calm After Storm Range Contraction 0.00%
    NR7 Range Contraction 0.00%
    Upper Bollinger Band Touch Strength 0.00%
    Fell Below 50 DMA Bearish -1.93%
    Spinning Top Other -1.93%
    Calm After Storm Range Contraction -1.93%
    Inside Day Range Contraction -1.93%
    Upper Bollinger Band Touch Strength -1.93%
    200 DMA Resistance Bearish -3.12%
    Older End-of-Day Signals for DNLI ...

       Recent Intraday Alerts

    Alert Time
    Down 1% 1 day ago
    60 Minute Opening Range Breakdown 1 day ago
    50 DMA Support 1 day ago
    Rose Above 50 DMA 1 day ago
    Rose Above Upper Bollinger Band 1 day ago
    View Earlier Intraday Alerts

    Get a Trading Sidekick!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Track My Stocks
    Configure default chart indicators
    DNLI Chart by TradingView
    Basic chart:

    Profile

    Denali Therapeutics Inc is a clinical-stage biopharmaceutical company. The company is engaged in developing therapeutics for neurodegenerative diseases, including Alzheimer's disease, Parkinson's disease and amyotrophic lateral sclerosis.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Biopharmaceutical Organ Systems Neuroscience Alzheimer's Disease Parkinson's Disease Neurological Disorders Neurodegenerative Diseases Amyotrophic Lateral Sclerosis Degenerative Disease Neurodegeneration Senescence

    Is DNLI a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    May 9 Denali Therapeutics First Quarter 2024 Earnings: US$0.68 loss per share (vs US$0.80 loss in 1Q 2023)
    May 8 Denali (DNLI) Q1 Earnings Miss, Pipeline Progress in Focus
    May 7 Denali Therapeutics Q1 2024 Earnings: Misses Revenue Estimates Amid Strategic Shifts
    May 7 Denali Therapeutics GAAP EPS of -$0.68 beats by $0.02
    May 7 Denali Therapeutics Reports First Quarter 2024 Financial Results and Business Highlights
    May 1 Denali Therapeutics Announces Completion of Enrollment for Regimen G Evaluating eIF2B Agonist DNL343 in the Phase 2/3 HEALEY ALS Platform Trial
    Apr 29 Is There An Opportunity With Denali Therapeutics Inc.'s (NASDAQ:DNLI) 50% Undervaluation?
    Apr 9 Why Denali Therapeutics (DNLI) Stock Might be a Great Pick
    Mar 29 Sarepta Therapeutics (SRPT) Up 1.2% Since Last Earnings Report: Can It Continue?
    Mar 28 Why Is Denali Therapeutics (DNLI) Up 2.8% Since Last Earnings Report?
    See more DNLI news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 33.31
    52 Week Low 14.56
    Average Volume 1,128,750
    200-Day Moving Average 20.11
    50-Day Moving Average 18.73
    20-Day Moving Average 16.68
    10-Day Moving Average 17.10
    Average True Range 1.00
    RSI (14) 55.95
    ADX 22.11
    +DI 36.56
    -DI 19.21
    Chandelier Exit (Long, 3 ATRs) 17.24
    Chandelier Exit (Short, 3 ATRs) 17.57
    Upper Bollinger Bands 18.87
    Lower Bollinger Band 14.50
    Percent B (%b) 0.87
    BandWidth 26.17
    MACD Line -0.10
    MACD Signal Line -0.52
    MACD Histogram 0.4152
    Fundamentals Value
    Market Cap 2.53 Billion
    Num Shares 138 Million
    EPS -0.94
    Price-to-Earnings (P/E) Ratio -19.48
    Price-to-Sales 7.32
    Price-to-Book 2.23
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 19.33
    Resistance 3 (R3) 19.43 19.19 19.16
    Resistance 2 (R2) 19.19 18.93 19.14 19.10
    Resistance 1 (R1) 18.75 18.77 18.63 18.65 19.05
    Pivot Point 18.51 18.51 18.45 18.46 18.51
    Support 1 (S1) 18.07 18.25 17.95 17.97 17.57
    Support 2 (S2) 17.83 18.09 17.78 17.52
    Support 3 (S3) 17.39 17.83 17.46
    Support 4 (S4) 17.29